List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 67 studies with search of: cancer nanoparticle
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
2 Not yet recruiting C-VISA BikDD: Liposome in Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Genetic: BikDD Nanoparticle
3 Recruiting A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer
Condition: Advanced Breast Cancer
Intervention: Drug: Nanoxel (Paclitaxel Nanoparticle formulation )
4 Recruiting Bevacizumab and Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: ixabepilone;   Drug: paclitaxel;   Drug: paclitaxel albumin-stabilized nanoparticle formulation
5 Active, not recruiting Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Biological: pegfilgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: immunoscintigraphy
6 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Carboplatin, and Bevacizumab in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Genetic: gene expression analysis;   Other: immunohistochemistry staining method;   Procedure: adjuvant therapy;   Procedure: axillary lymph node dissection;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
7 Recruiting Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Procedure: neoadjuvant therapy
8 Recruiting Weekly Abraxane (Paclitaxel Albumin-Stabilized Nanoparticle Formulation) and RAD001 (Everolimus) in Women With Locally Advanced or Metastatic Breast Cancer: A Study of the Cancer Institute of New Jersey Oncology Group (CINJOG)
Condition: Breast Cancer
Interventions: Drug: everolimus;   Drug: paclitaxel albumin-stabilized nanoparticle formulation
9 Not yet recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Biological: pegfilgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation
10 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: pharmacological study;   Other: physiologic testing;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: cognitive assessment;   Procedure: psychosocial assessment and care
11 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Cisplatin, and Cetuximab Given Together With Radiation Therapy in Treating Patients With Locally Advanced Stage III or Stage IV Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
12 Withdrawn Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Condition: Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Procedure: gene expression analysis;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study;   Procedure: polymerase chain reaction
13 Recruiting Topical Imiquimod and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastatic Cancer
Interventions: Drug: imiquimod;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Genetic: RNA analysis;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
14 Recruiting Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
15 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed by Bevacizumab and Erlotinib in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: laboratory biomarker analysis
16 Recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors
Conditions: Breast Cancer;   Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: pemetrexed disodium
17 Recruiting GM-CSF and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Biological: sargramostim;   Drug: paclitaxel albumin-stabilized nanoparticle formulation
18 Active, not recruiting Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Bevacizumab, and Gemcitabine as First-Line Therapy in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Genetic: protein expression analysis;   Other: immunologic technique;   Other: laboratory biomarker analysis
19 Terminated Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: sunitinib malate
20 Recruiting Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Vorinostat in Treating Women With Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: vorinostat;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services